| RS2517574850 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517575259 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517575718 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517575875 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517576039 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517576148 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517577085 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517578279 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517578591 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517578772 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517578834 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517579169 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517579439 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517579694 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517579917 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517580522 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517580853 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517581052 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517581250 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517582025 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517582422 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517583431 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517583520 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517583529 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517583657 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517583664 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517585923 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517588823 |
MORC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, Charcot-Marie-Tooth disease axonal type 2Z |
| RS2517589745 |
ZNRF3
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517589753 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517589889 |
MORC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, Charcot-Marie-Tooth disease axonal type 2Z |
| RS2517590778 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517591012 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517591405 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517591470 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517591496 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517591567 |
ZNRF3
|
Health Risk |
Pathogenic |
ZNRF3-related disorder, ZNRF3-related disorder |
| RS2517595954 |
CNOT3
|
Health Risk |
Pathogenic |
— |
| RS2517601712 |
MORC2
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired growth |
| RS2517605174 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517607780 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517608676 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517609684 |
TRAPPC10
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, short stature |
| RS2517611666 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2517612562 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517618157 |
SYNJ1
|
Health Risk |
Likely pathogenic |
— |
| RS2517619244 |
SYNJ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2517621673 |
MORC2
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired growth |
| RS2517621695 |
CHCHD10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant mitochondrial myopathy with exercise intolerance, Lower motor neuron syndrome with late-adult onset |
| RS2517622850 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517627198 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517639832 |
PRPF6
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2517649919 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517652434 |
SMARCB1
|
Health Risk |
Likely pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS2517652550 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517652605 |
SMARCB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2517653620 |
CDC45
|
Health Risk |
Pathogenic |
— |
| RS2517655700 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2517655719 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2517658835 |
CDC45
|
Health Risk |
Pathogenic |
— |
| RS2517660427 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2517660810 |
SMARCB1
|
Health Risk |
Pathogenic |
Developmental disorder, Hereditary cancer-predisposing syndrome |
| RS2517661534 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517662048 |
SLC5A1
|
Health Risk |
Pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS2517662992 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517663296 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517663308 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517663841 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517663914 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517664271 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517664783 |
SMARCB1
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS2517666052 |
PEX26
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517666120 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517666229 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517666301 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517670720 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517670730 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517670734 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517670768 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517670770 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517670893 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517671009 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517673366 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517673461 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS2517673510 |
SLC5A1
|
Health Risk |
Pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS2517673596 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS2517675398 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2517676428 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2517676690 |
CDC45
|
Health Risk |
Pathogenic |
— |
| RS2517677261 |
SLC5A1
|
Health Risk |
Pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS2517679712 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2517679862 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2517683028 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2517683432 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517684135 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2517684307 |
SMARCB1
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 1, Rhabdoid tumor predisposition syndrome 1 |
| RS2517684309 |
KREMEN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517690574 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2517690624 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517693412 |
KCTD17
|
Health Risk |
Pathogenic |
Myoclonic dystonia 26, Myoclonic dystonia 26 |